RxDoctor Payments Data

Matthew Johnson, MD

Urology · Milwaukee, WINPI 1881685808

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,000 of the $9,596 with a category attached, or 62.5%. Intuitive Surgical accounts for 79.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $4,271 and has fallen 86.4% since, to $580 in 2025. Among urology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,596in general payments, 2019–2025

Across 35 payments — averaging $274.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$8K
  • Teleflex LLC$1K
  • Calyxo, Inc.$520
  • Neotract Inc.$138
  • Agiliti Surgical, Inc.$61
  • Procept Biorobotics Corporation$60
  • plus $73 from 2 others

What the payments were for

  • Travel & lodging$1,49516%
  • Food & beverage$2,09222%
  • Education$6,00063%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,596 in reported general payments places this provider in the 90th percentile of 215 urology providers in Wisconsin.

See all urology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$234,206
Medicare patients
559
Services billed
4,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron48$34,973
Tamsulosin Hcl1,062$13,922
Solifenacin Succinate204$8,654
Alfuzosin Hcl ErAlfuzosin Hcl145$3,501
Trimethoprim23$1,999
Oxybutynin Chloride113$1,722
Finasteride107$1,246
Methenamine Hippurate12$648
Bethanechol Chloride21$511
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst39$428
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim100$396
Diclofenac Potassium46$192
Cephalexin11$137
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$80
Ciprofloxacin Hcl19$74

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$48$34,97348 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 215 urology providers in Wisconsin.

Other urology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →